Navigation Links
Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel
Date:2/5/2008

MISSISSAUGA, ON, Feb. 5 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), a biotechnology Company focused on the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, today announced that Chris Waddick, President and CEO, will present a Company Overview at BIO CEO & Investor Conference at the Waldorf Astoria, New York City, at 11:00 a.m. (ET) on Tuesday, February 12, 2008. The presentation will be webcast live at http://www.vasogen.com and a replay will also be accessible at http://www.vasogen.com.

Dr. Eldon Smith, Vasogen's Senior Vice President, Scientific Affairs and Chief Medical Officer, has also been selected as a member of the expert panel of the Non-Cancer Immunotherapy session. This workshop will take place on Wednesday, February 13, 2008, at 9:30 a.m. (ET). This event will not be webcast.

About Vasogen:

Vasogen is a biotechnology company engaged in the research and commercial development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. The Company's lead product, the Celacade(TM) System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is being marketed in the EU by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage clinical development for the treatment of chronic heart failure in the United States. Vasogen is al
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Vasogen Announces 2007 Year-End Results
8. The Lancet Publishes Vasogens ACCLAIM Results
9. Vasogens Research Published in European Journal of Neuroscience
10. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
11. Avicena Group to Present at Noble Financial Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ec. 1 GeoVax Labs, Inc....tlanta-based, biopharmaceutical company developing...n Immunodeficiency Virus) and other infectious age...y. ,, "Today is the 21st World AIDS Day and as ...t with the HIV/AIDS pandemic, we remain focused an...
(Date:12/1/2009)... A new clinical study presented to the American S...dimensional (3-D) automated ultrasound follicle me... vitro fertilization (IVF) cycle is effective and ... of the follicles. , Gurn...rtility Center of Chicago has just completed resea...
(Date:12/1/2009)... iCardiac now provides services to three out of t... Rochester, NY (PRWEB) December ...eader in advanced cardiac core lab services and QT...eutical company has selected iCardiac as a preferr... provide Highly Automated QT(sm) and Dynamic QT be...
(Date:12/1/2009)... Michael R. Drapp, a 34-year veteran of the high-...chnologies, a business development and intellectua...ing nanotechnology space. The company also plans ...anotechnology incubator. , ...l R. Drapp , a 34-year veteran of the high-technol...
Breaking Biology Technology:GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4
...Ltd., the Innovator in,Ultrasound for more than 50...trasound systems with dedicated platforms for adva...pha 10 and the ProSound Alpha 7 at,Scientific Sess...nge County,Convention Center in Orlando, Florida, ...Alpha 10 incorporate all of the standard,cardiovas...
...obial/Anti-fingerprint/Easy-To-Clean Coatings, For...ess Group To Spin-Off ...ast-growing global,demand for specially formulated...int and easy-to-clean characteristics to enhance t... products and surfaces,Horizon Business Group has ...
...ribution of Corvalen(R) (D-ribose) products to ...APOLIS, and GREEN BAY, Wis., Oct. 29 Bioenergy,Li...Therapeutics, Inc.,(ITI), a division of Enzymatic ... entered into an exclusive co-marketing alliance. ..., developed by Bioenergy Life Science,to its estab...
Other Biology Technology:ALOKA to Introduce New 'ProSound' Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida 2ALOKA to Introduce New 'ProSound' Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida 3Sureshield Coatings Company Established to Market Industry-Leading Portfolio of Advanced Coatings for Metal Surfaces 2Sureshield Coatings Company Established to Market Industry-Leading Portfolio of Advanced Coatings for Metal Surfaces 3Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance 2Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance 3
(Date:12/1/2009)...stery, and it is a question which has continued to... plants evolve and how did they come to dominate p...ers reveals the evolutionary trigger which led to...e advantage over rival species, leading to their s... Tim Brodribb and Dr Taylor Field of the Universi...
(Date:11/30/2009)...e of Antarctica,s climate and its relationship to ...Tuesday 1 December) by the Scientific Committee on...c Climate Change and the Environment presents the...s areas for future scientific research, and addres...bout Antarctic melting, sea-level rise and biodive...
(Date:11/30/2009)...overcame a major hurdle plaguing the development o...ore efficient catalysts used to produce hydrogen a...reported Nov. 29 in Nature Materials the first d...llic nanoparticles, the vaunted next-generation ma...t. , Gtz Veser, an associate professor and CNG F...
Breaking Biology News(10 mins):How did flowering plants evolve to dominate Earth? 2First comprehensive review of the state of Antarctica's climate 2First metallic nanoparticles resistant to extreme heat 2Buyer Beware 21 Know What Youre Getting When You Buy Online Genetic Tests 51087 1Buyer Beware 21 Know What Youre Getting When You Buy Online Genetic Tests 51087 2Buyer Beware 21 Know What Youre Getting When You Buy Online Genetic Tests 51087 3March of Dimes Names Two New Trustees 51084 1March of Dimes Names Two New Trustees 51084 2Evidence based information about complementary and alternative medicine treatments now available 51081 1Evidence based information about complementary and alternative medicine treatments now available 51081 2
...a development that could lead to new technologies ...r, scientists at Rice University have shown how ti... trap oil droplets in water by spontaneously assem...re found to assemble spontaneously by the tens of ...s around droplets of oil in water. In addition, th...
...destructive imaging technology of the future? Micr...tz (GHz) up to slightly over 1 terahertz (THz), pe...t the ionizing damage caused by X-rays. The techno...dental flaws beneath the enamel. It could also be ...jects hidden under clothing. , Most of these appli...
...Molecular Biology Laboratory (EMBL) in Heidelberg,...titute (EMBL-EBI) in Hinxton, UK, have revealed ne... A chromatin modifying enzyme helps compensate for... chromosome X, while females have two. The enzyme ...mes in fruit flies and binds to different location...
Other Biology News:Nanoparticles assemble by millions to encase oil drops 2How to make microwaves on a chip to replace X-rays for medical imaging and security 2X chromosome exposed 2
Mouse Anti-Aequorin Monoclonal Antibody, Unconjugated, Clone 2Q2147 from Abcam
Anti-Phosphotyrosine IgG Monoclonal Antibody, Alkaline Phosphatase Conjugated, Clone AD548 from Assay Designs/Stressgen Bioreagents
... mixed TAMRA isomers are predominantly used for la...ly preferred for labeling peptides and nucleotides...ication that is often required in the conjugation ... for labeling peptides and proteins. 6-TAMRA is pr...
Chicken Anti-Lactate Dehydrogenase Antibody, Unconjugated from Immunology Consultants Laboratory, Inc.
Biology Products: